Safety and Immunovirologic Outcomes with Maraviroc Combination Regimens in Patients with a History of Past Treatment Failures and Virologic Resistance in Brazil: An Open-Label, Multicenter Phase 3b StudyJuvêncio José Duailibe Furtado, Lourenia M. Cassoli, Eliana L. Bicudo et al.|AIDS Research and Human Retroviruses|2013Cited by 5